Source:British Journal of Oral and Maxillofacial Surgery
Author(s): R. Ratansi, J. Hoole, D.A. Mitchell, A. Kanatas
from OroFacial Medicine via ola Kala on Inoreader http://ift.tt/2rNsYFp
via IFTTT
http://ift.tt/2rwxR6d
Δευτέρα 19 Ιουνίου 2017
Why don’t we mention “impact on intimacy” when we ask patients to give consent for treatment of oral cancer?
Source:British Journal of Oral and Maxillofacial Surgery
Author(s): R. Ratansi, J. Hoole, D.A. Mitchell, A. Kanatas
from OroFacial Medicine via ola Kala on Inoreader http://ift.tt/2rNsYFp
via IFTTT
http://ift.tt/2rwxR6d
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose To determine the differences in acromegaly diagnosis, treatment, and follow-up among Turkish endocrinologists, and to inv...
-
Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations : To evaluate histologic subtype and grade, which i...
-
Complex‐centric proteome profiling by SEC‐SWATH‐MS The study presents an integrated framework for targeted, complex‐centric analysis based o...
-
Nonsyndromic supernumerary bilateral parapremolars : Vineeta Singhal, D Deepa Journal of Oral Research and Review 2017 9(2):82-84 Su...
-
Current treatments for generalized pustular psoriasis are unsatisfactory. We applied recently-developed techniques for transcriptomic analys...
-
Abstract Malakoplakia is a rare inflammatory condition that typically occurs in the urinary tract. The cutaneous form is less prevalent, an...
-
H22954, a novel long non-coding RNA down-regulated in AML, inhibits cancer growth in a BCL-2-dependent mechanism Publication date: 10 July 2...
-
Description A 65-year-old man presented with fever and painful swelling at the back for last 2 weeks. His prior history was significant for...
-
Effect of Ketoconazole, a Strong CYP3A Inhibitor, on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor, in Patients with Non-Hodgkin Lym...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου